CHRISTUS Shreveport-Bossier Health System-Highland
1453 E Bert Kouns Industrial Loop, Shreveport, LA · Christushealth · · NPI 1417950106
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.13 – $0.14 | 14 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $448.70 – $503.65 | 15 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $37.40 – $42.70 | 2 |
| Inj. insulin (fiasp) HCPCS J1812 | not published | not published | $2.04 – $2.04 | 1 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $151.00 – $328.78 | 15 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $151.00 – $328.78 | 15 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $11.69 – $13.12 | 14 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.82 – $2.29 | 14 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $1.94 – $2.55 | 15 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.34 – $1.54 | 15 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $2.26 – $2.26 | 1 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $80.07 – $109.02 | 2 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $28.42 – $31.90 | 14 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.23 – $1.39 | 14 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $0.76 – $0.79 | 2 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $20.36 – $22.86 | 14 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $23.17 – $45.48 | 3 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.02 – $1.09 | 3 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $2.82 – $3.97 | 14 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $4.76 – $5.35 | 14 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $15.20 – $15.20 | 1 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $2,957,725.71 – $3,319,896.21 | 14 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $294.58 – $330.65 | 15 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $21.67 – $25.73 | 15 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $2,900.20 – $3,299.34 | 15 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $3.38 – $3.99 | 2 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $123.84 – $229.25 | 15 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $549.85 – $549.85 | 1 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $716.78 – $804.55 | 14 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $107.82 – $210.48 | 2 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $2.24 – $2.24 | 1 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $1.78 – $2.19 | 15 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $1.06 – $2.95 | 3 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.52 – $0.52 | 1 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $36.82 – $47.19 | 14 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $225.39 – $252.99 | 15 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $23.36 – $26.22 | 14 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $9.31 – $17.12 | 3 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $8.01 – $8.01 | 1 |
| Inj multihance HCPCS A9577 | not published | not published | $1.94 – $4.28 | 3 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $1.92 – $4.10 | 3 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.57 – $0.57 | 1 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $9.90 – $59.39 | 3 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $549.94 – $667.82 | 15 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.01 – $2.26 | 14 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $87.88 – $98.64 | 14 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $483.29 – $3,052.16 | 19 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $483.29 – $3,052.16 | 19 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $1,066.68 – $2,156.31 | 2 |
| Inj octafluoropropane mic,ml HCPCS Q9956 | not published | not published | $33.99 – $70.02 | 3 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $53.05 – $62.48 | 2 |
| Inj, oliceridine 0.1 mg HCPCS C9101 | not published | not published | $1.23 – $1.38 | 14 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $353.47 – $396.75 | 14 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $3.63 – $4.10 | 15 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $3.63 – $4.08 | 15 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $2,226,361.33 – $2,498,977.01 | 14 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $24.43 – $58.50 | 15 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $55.34 – $62.12 | 14 |
| Inj pantoprazole(hikma) 40mg HCPCS J2471 | not published | not published | $8.27 – $8.27 | 1 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $64.00 – $71.84 | 14 |
| Inj, pasireotide long acting HCPCS J2502 | not published | not published | $486.75 – $554.70 | 15 |
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $91.55 – $107.53 | 15 |
| Inj, pedmark, 100 mg HCPCS J0208 | not published | not published | $88.93 – $99.81 | 14 |
| Inj, pegcetacoplan, 1mg HCPCS J2781 | not published | not published | $135.58 – $152.19 | 14 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $22.89 – $203.65 | 15 |
| Inj, pegulicianine, 1 mg HCPCS A9615 | not published | not published | $34.75 – $39.01 | 14 |
| Inj. pemetrexed, 10 mg HCPCS J9304 | not published | not published | $48.81 – $54.79 | 14 |
| Inj pemetrexed (accord) 10mg HCPCS J9296 | not published | not published | $9.03 – $10.13 | 14 |
| Inj pemetrexed ditromethamin HCPCS J9323 | not published | not published | $4.97 – $10.97 | 14 |
| Inj pemetrexed, hospira 10mg HCPCS J9294 | not published | not published | $2.09 – $2.67 | 14 |
| Inj pemetrexed (sandoz) 10mg HCPCS J9297 | not published | not published | $1.19 – $1.19 | 1 |
| Inj pemetrexed (teva) 10mg HCPCS J9314 | not published | not published | $6.62 – $7.43 | 14 |
| Inj, pemivibart, 4500 mg HCPCS Q0224 | not published | not published | $6,978.51 – $6,978.51 | 1 |
| Inj, pemrydi rtu, 10 mg HCPCS J9324 | not published | not published | $76.09 – $85.40 | 14 |
| Inj perflexane lip micros,ml HCPCS Q9955 | not published | not published | $15.39 – $27.30 | 2 |
| Inj., perseris, 0.5 mg HCPCS J2798 | not published | not published | $11.29 – $12.67 | 15 |
| Inj plasminogen tvmh 1mg HCPCS J2998 | not published | not published | $30.13 – $33.81 | 14 |
| Inj., plazomicin, 5 mg HCPCS J0291 | not published | not published | $3.30 – $3.71 | 15 |
| Inj pozelimab-bbfg, 1 mg HCPCS J9376 | not published | not published | $110.08 – $110.08 | 1 |
| Inj proc for lymphang CPT 38790 | not published | not published | $3,045.00 – $3,045.00 | 1 |
| Inj progesterone per 50 mg HCPCS J2675 | not published | not published | $0.77 – $3.01 | 3 |
| Inj prohance multipack HCPCS A9576 | not published | not published | $1.56 – $3.56 | 3 |
| Inj protirelin per 250 mcg HCPCS J2725 | not published | not published | $24.40 – $53.56 | 2 |
| Inj recombin esperoct per iu HCPCS J7204 | not published | not published | $2.01 – $2.28 | 15 |
| Inj, releuko 1 mcg HCPCS Q5125 | not published | not published | $0.42 – $0.47 | 14 |
| Inj retro urethrocysto CPT 51610 | not published | not published | $452.08 – $3,045.00 | 2 |
| Inj, rimabotulinumtoxinb HCPCS J0587 | not published | not published | $12.03 – $13.51 | 15 |
| Inj roctavian ml 2x10^13vc g HCPCS J1412 | not published | not published | $10,808.22 – $12,131.68 | 14 |
| Inj., rolapitant, 0.5 mg HCPCS J2797 | not published | not published | $0.95 – $0.95 | 1 |
| Inj romidepsin non-lyo 0.1mg HCPCS J9318 | not published | not published | $26.42 – $34.54 | 15 |
| Inj, rykindo, 0.5 mg HCPCS J2801 | not published | not published | $12.07 – $13.55 | 14 |
| Inj scleros sol mult veins CPT 36471 | not published | not published | $151.00 – $604.82 | 15 |
| Inj, sculptra, 0.5mg HCPCS Q2028 | not published | not published | $0.73 – $1.05 | 15 |
| Inj sebelipase alfa 1 mg HCPCS J2840 | not published | not published | $493.14 – $560.97 | 15 |
| Inj secretin synthetic human HCPCS J2850 | not published | not published | $35.44 – $44.26 | 15 |
| Inj secukinumab intrav 1mg HCPCS J3247 | not published | not published | $16.42 – $18.43 | 14 |
| Inj, sezaby, 1 mg HCPCS J2561 | not published | not published | $0.60 – $0.67 | 14 |
| Inj, spesolimab-sbzo, 1 mg HCPCS J1747 | not published | not published | $56.90 – $63.87 | 14 |
| Inj(s) sclerosant spider veins limb/trunk CPT 36468 | not published | not published | $151.00 – $415.40 | 15 |
| Inj, susvimo 0.1 mg HCPCS J2779 | not published | not published | $74.53 – $83.66 | 14 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.